Breast Lesion Localization Methods Market

The global breast lesion localization methods market size was valued at USD 0.98 Billion in 2022 and is anticipated to reach USD 2.56 Billion by 2031, expanding at a CAGR of 11.2% during the forecast period, 2023–2031. The growth of the market is attributed to the rising incidence of breast cancer and growing awareness on the early detection of breast cancer. Moreover, increasing demand for breast cancer surgeries present another key aspect of the market expansion.

Breast cancer is one of the most common types of cancer among women and breast lesion is widely occurred due to abnormal change in tissues or organs around breast. As per the data of World Health Organization (WHO), breast cancer has become a major health issue among women and it accounted for nearly 12% of the overall new cancer cases in 2021 globally.

Get Free Sample Report

As per the US Breast Cancer Statistics published in Feb 2021, one in eight women in the US was likely to develop breast cancer. The report further stated that the total number of new cases of invasive breast cancer in the country was around 280,000 and an estimated of 49,290 new cases for non-invasive (in situ) breast cancer.

However, in many cases, breast legion is found to be benign despite the rapid and abnormal growth of breast cells, which may result to non-cancerous disorder. For the treatment of such disorder, several localization methods are widely adopted by patients. One key aspect of the market growth can be accredited to growing adoption of awareness and free screening programs related to the disorder.

For example, under the initiative of the Government of Australia, a national breast cancer screening program called Breast Screen Australia was initiated, which would offer free mammogram tests to women aged 50 to 74 every two years. Programs encouraging early diagnosis is also being regularly promoted in developing countries such as India and China.

Breast Lesion Localization Methods Market Trends, Drivers, Restraints, and Opportunities

• Wide prevalence of breast cancer and rising government participation across the globe encouraging the early adoption of breast cancer screening are projected to grow the market expansion.
• Rising demand for better healthcare infrastructure and services as well as increasing awareness about breast cancer screening are expected to boost market growth.
• Favorable reimbursement policies for breast cancer diagnostics, biopsy, and other relevant medical procedures are major factors driving the market growth during the forecast period.
• High cost of the treatment acts as a major challenge that can hamper the market growth in the coming years.
• Recent launch of technologically advanced products offering high accuracy, safety, and cost-effectiveness present several opportunities for the market expansion in the coming years.

Scope of Breast Lesion Localization Methods Market Report

The report on the global breast lesion localization methods market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Breast Lesion Localization Methods Market Segment Insights

Types Segment Analysis

Based on types, the global breast lesion localization methods market is divided into wire guided, radioisotope localization, magnetic tracer, and others. The radioisotope localization segment is further bifurcated into radio guided occult-lesion localization and radioactive-seed localization. The wire guided segment is expected to account for a key share of the market owing to wide adoption of the treatment type among patients. 

On the other hand, the radioisotope segment is expected to grow significantly due to improved efficacy through novel mechanisms. Radioisotope is one of the most recently developed techniques for preoperative localization of non-palpable and suspicious lesions, which offer reliable, safe, and healthy result.

Meanwhile, the magnetic tracer is expected to expand at a fast growth rate during the forecast period owing to extensive used of the type to diagnose non-palpable cancer in the early stages. Sienna+ is one of the most widely used brands of magnetic tracer for the cancer detection.

Moreover, the segment growth can be attributed to rising adoption of new techniques and early acceptance of innovative technology in the treatment. RPLN, Duo-System, Q-wire system, and X-Reidy breast lesion localization needles are some of the most commonly used methods for the localization systems.

Get Free Sample Report

Regional Analysis

In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is projected to constitute a large market share during the forecast period owing to the presence of well-established healthcare infrastructure and key manufacturers especially in the US. The regional market growth is also further driven by technological advancement and high economic growth in this region.

On the other hand, the market of Asia Pacific is projected to grow at a rapid pace during the forecast period due to several factors such as growing disposable income levels, high unmet health needs, and increasing patient knowledge about early diagnosis among the patients in the region.

Furthermore, the region's potential growth is expected to be bolstered by rapidly growing investment for the development of healthcare infrastructure and rising demand for breast conserving surgery solutions.
 

Get Free Sample Report

Segments

The global breast lesion localization methods market has been segmented on the basis of

Types

• Wire Guided
• Radioisotope Localization
  • Radio Guided Occult-lesion Localization
  • Radioactive-seed Localization
• Magnetic Tracer
• Others

Regions

• Asia Pacific
• North America
• Latin America
• Europe
• Middle East & Africa

Key Players

• C.R. Bard
• SOMATEX Medical Technologies GmbH
• Argon Medical Devices, Inc.
• Cianna Medical, Inc.
• Cook Medical
• C.P. Medical

Competitive Landscape

Some of the key players operating in the market are C.R. Bard; SOMATEX Medical Technologies GmbH; Argon Medical Devices, Inc.; Cianna Medical, Inc.; Cook Medical; and C.P. Medical. In order to expand their market share, these market players are concentrating on business expansion in developing regions and are actively engaged in various business tactics such as mergers, acquisitions, and product launches.

• Cianna Medical, Inc. signed a merger agreement with Merit Medical Systems, Inc. in October 2018. Under the deal, the latter company agreed to provide clinical support for Cianna Medical, Inc.'s research and development in order to commercialize new technologies in the market.

• In another event, Endomagnetics and Cianna Inc. have developed a new set of techniques for locating breast lesions based on magnetic and electroradar guidance respectively. Cianna Medical, Inc.'s SAVI SCOUT localization technology has completed more than 50,000 breast tumor localizations in over 375 hospitals across the US.

• C.R. Bard and BD announced an agreement in April 2017 to develop differentiated medical technologies with an aim to enhance the process of disease care and treatment for patients.